- Home
- INVA vs DX Comparison
INVA vs DX Comparison
Compare INVA & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- DX
- Stock Information
- Founded
- INVA 1996
- DX 1987
- Country
- INVA United States
- DX United States
- Employees
- INVA N/A
- DX N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- DX Real Estate Investment Trusts
- Sector
- INVA Health Care
- DX Real Estate
- Exchange
- INVA Nasdaq
- DX Nasdaq
- Market Cap
- INVA 1.1B
- DX 1.1B
- IPO Year
- INVA 2004
- DX N/A
- Fundamental
- Price
- INVA $18.08
- DX $14.06
- Analyst Decision
- INVA Buy
- DX Buy
- Analyst Count
- INVA 1
- DX 6
- Target Price
- INVA N/A
- DX $13.33
- AVG Volume (30 Days)
- INVA 436.3K
- DX 2.8M
- Earning Date
- INVA 03-07-2025
- DX 01-27-2025
- Dividend Yield
- INVA N/A
- DX 12.87%
- EPS Growth
- INVA 46.55
- DX N/A
- EPS
- INVA 0.99
- DX 1.49
- Revenue
- INVA $352,745,000.00
- DX $150,396,000.00
- Revenue This Year
- INVA $16.20
- DX N/A
- Revenue Next Year
- INVA N/A
- DX $8.64
- P/E Ratio
- INVA $18.25
- DX $9.44
- Revenue Growth
- INVA 21.46
- DX 462.25
- 52 Week Low
- INVA $14.33
- DX $11.36
- 52 Week High
- INVA $21.28
- DX $14.21
- Technical
- Relative Strength Index (RSI)
- INVA 45.13
- DX 77.46
- Support Level
- INVA $17.92
- DX $13.67
- Resistance Level
- INVA $18.20
- DX $13.85
- Average True Range (ATR)
- INVA 0.26
- DX 0.18
- MACD
- INVA -0.04
- DX 0.06
- Stochastic Oscillator
- INVA 33.33
- DX 87.30
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including residential MBS and commercial MBS.